Samphire Neuroscience Raises $2.3M in Pre-seed Funding for Novel Neurotechnology Wearable Targeting PMS & Menstrual Pain
Amount Raised
$2.3 Million
Round Type
Pre-Seed
Investors
Description
Samphire Neuroscience has successfully raised $2.3 million in pre-seed funding for its pioneering neurotechnology wearable, Nettle, designed to manage PMS and menstrual pain. The funding round drew contributions from venture firms experienced in medical devices and women’s health, as well as prominent angel investors.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Samphire Neuroscience that raised within 45 days of this round, from Fundz verified event records.
- NeuroVigil raised $85M (Series B) on April 6, 2024.
- Enlaza Therapeutics raised $84M on April 5, 2024.
- Syntropic Medical raised an undisclosed amount (Funding Round) on April 5, 2024.
- Mural Health raised $13M on April 5, 2024.
- Beacon Therapeutics raised $120M (Series A) on April 5, 2024.
- Curelo raised $1.2M (Seed) on April 4, 2024.
Who to call at Samphire Neuroscience, and when
A new round usually means Samphire Neuroscience is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Samphire Neuroscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Samphire Neuroscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Samphire Neuroscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Samphire Neuroscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Samphire Neuroscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.